Castleark Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-232
Closed -$41K 404
2020
Q1
$41K Hold
232
﹤0.01% 315
2019
Q4
$44K Hold
232
﹤0.01% 325
2019
Q3
$39K Hold
232
﹤0.01% 334
2019
Q2
$39K Hold
232
﹤0.01% 341
2019
Q1
$34K Hold
232
﹤0.01% 355
2018
Q4
$31K Hold
232
﹤0.01% 361
2018
Q3
$44K Hold
232
﹤0.01% 363
2018
Q2
$39K Hold
232
﹤0.01% 363
2018
Q1
$39K Hold
232
﹤0.01% 397
2017
Q4
$38K Hold
232
﹤0.01% 396
2017
Q3
$48K Hold
232
﹤0.01% 376
2017
Q2
$56K Hold
232
﹤0.01% 378
2017
Q1
$55K Sell
232
-209
-47% -$48.7K ﹤0.01% 357
2016
Q4
$93K Hold
441
﹤0.01% 361
2016
Q3
$102K Hold
441
﹤0.01% 361
2016
Q2
$102K Hold
441
﹤0.01% 358
2016
Q1
$118K Buy
+441
New +$126K ﹤0.01% 346
2015
Q4
Sell
-441
Closed -$120K 434
2015
Q3
$120K Buy
+441
New +$135K ﹤0.01% 350
2015
Q2
Sell
-882
Closed -$262K 402
2015
Q1
$262K Buy
+882
New +$251K 0.01% 334

Other funds holding AGN

Castleark Management's AGN Position: Q2 2020 in Review

Castleark Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 232 shares — an estimated $41K sold.

Castleark Management first reported a position in AGN in Q1 2015 and held it in 19 quarters. The position peaked at $262K in Q1 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Castleark Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Castleark Management sold 232 Allergan plc shares in Q2 2020, an estimated $41K.
  • Castleark Management first reported a position in Allergan plc in Q1 2015 and held it in 19 quarters.
  • Castleark Management's Allergan plc position peaked at $262K in Q1 2015.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Castleark Management's 13F filing for Q2 2020, filed 14 Aug 2020.